IMR Press / EJGO / Special Issues / 1635841030941

Update on Cervical Cancer Prevention and Screening 2022

Submission deadline: 30 April 2022
Special Issue Editors
Tiziano Maggino, MD, PhD
Department of Obstetrics and Gynaecology, Dell'Angelo General Hospital, Venice, Italy
Interests: Obstetrics and gynecology; Cervical cancer screening; Gynecology oncology
Special Issue and Collections in IMR journals
Special Issue Information

Dear Colleagues,
Cervical cancer of the uterus is a neoplasia in which the scientific progress has produced an impressive reduction in the incidence and mortality.
This is particurlaly linked with several development in the knowledge of the natural history of the disease:
● The patogenetic role of HPV infection has been definivelly well established with a clear multistep process of development;
● The organized population based cervical cancer screening programmes at national and regional level have produced an increasing detection of dysplasic and early invasive lesions particularly in young women;
● Introduction of HPV- high risk test as primary screening test has produce an anticipation of the detection of the dysplasic lesions;
● More conservative treatments have been proposed for the screen-detected lesions with consequent respect of the anatomo-functional integrity of the uterine cervix;
● Recently some markers of progression may be identified aiming to select which lesion requires follow-up istead of immediate treatment;
● Vaccination agaist HPV has been introduced in many western countries with an expected further reduction in the incidence of the disease;
● The first cohorts of vaccinated girls have reached the age of screening programme and the consequance of this implies a substantial changes in the strategies of the screening programme in term of organization, test to adopt, frequancy and interpretation of the results.


The special issue of the journal will offer to the readers the highlights of the researches in the field presented by authors with recognized international experience and reporting, in some part, the actual position of the national group of cervical screening programmes in Italy.

Dr. Tiziano Maggino

Guest Editor

Keywords
Cervical cencer screening
HPV-vaccine
Cervical dysplasias
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top